Background GlycA is a novel spectroscopic marker of systemic inflammation with low intra-
individual variability and other attributes favoring its clinical use in patients with chronic …

Several studies suggest that variations in the concentration of plasma glycoproteins can
influence cellular changes in a large number of diseases. In recent years, proton nuclear …

Background Cancer cachexia is a metabolic disorder involving perturbed energy balance
and altered mitochondrial function. Chemotherapy is a primary treatment option for many …

Background Rheumatoid arthritis (RA) is a chronic inflammatory disease in which adults
have significant joint issues leading to poor health. Poor health is compounded by many …

Background Meal-induced metabolic changes trigger an acute inflammatory response,
contributing to chronic inflammation and associated diseases. Objectives We aimed to …

Rationale: GlycA, an emerging inflammatory biomarker, predicted cardiovascular events in
population-based studies. Psoriasis, an inflammatory disease associated with increased …

The GlycA test is a recently developed proton nuclear magnetic resonance (1H-NMR)
spectroscopy-based assay that has been gaining increased interest as a serum biomarker …

Background To identify molecular alterations in skeletal muscle in rheumatoid arthritis (RA)
that may contribute to ongoing disability in RA. Methods Persons with seropositive or erosive …

Inflammation is an important factor in Alzheimer's disease (AD). An NMR measurement in
plasma, glycoprotein acetyls (GlycA), captures the overall level of protein production and …

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease associated with a
high index of morbidity and mortality from cardiovascular diseases. We used 1H NMR to …